How many insider trades does FilingIQ track for CELU?

FilingIQ tracks 137 Form 4 insider transactions for CELU (Celularity Inc), covering filings from Jul 16, 2021 onwards. 9 of those were filed in the last 90 days.

Are CELU insiders net buyers or net sellers?

Across the full Form 4 history for CELU, 7 transactions (5%) were open-market purchases and 2 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CELU insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CELU in?

Celularity Inc (CELU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $38.93M.

CELU insider trading

NasdaqCM Healthcare

Celularity Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

137

Last 90 days

Buys / sells

5% / 1%

Market cap

$38.93M

About Celularity Inc

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Company website: www.celularity.com

CELU insider activity at a glance

FilingIQ has scored 137 insider transactions for CELU since Jul 16, 2021. The most recent filing in our index is dated Apr 13, 2026.

Across the full history, 7 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CELU insider trades is 69.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CELU trades on FilingIQ Raw filings on SEC EDGAR

Latest CELU Form 4 filings

Hariri Robert J Chief Executive Officer

P Sep 29, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CELU?: FilingIQ tracks 137 Form 4 insider transactions for CELU (Celularity Inc), covering filings from Jul 16, 2021 onwards. 9 of those were filed in the last 90 days.
Are CELU insiders net buyers or net sellers?: Across the full Form 4 history for CELU, 7 transactions (5%) were open-market purchases and 2 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CELU insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CELU in?: Celularity Inc (CELU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $38.93M.

Methodology & sources

Every CELU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.